Difference between revisions of "Aminocaproic acid (Amicar)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "[[File:" to "[[:File:")
 
(6 intermediate revisions by 3 users not shown)
Line 1: Line 1:
Also known as 6-aminohexanoic acid, epsilon aminocaproic acid, ε-aminocaproic acid, ε-Ahx.
 
 
 
==General information==
 
==General information==
Class/mechanism: Inhibits fibrinolysis by inhibiting plasminogen activators and via antiplasmin activity.<ref name="insert">[http://products.hospira.com/assets/pdfs/EN-1485.pdf Aminocaproic acid (Amicar) package insert]</ref><ref>[[Media:Aminocaproicacid.pdf | Aminocaproic acid (Amicar) package insert (locally hosted backup)]]</ref><ref>[[Media:Aminocaproicacidtablets.pdf | Aminocaproic acid tablets (Amicar) package insert (locally hosted backup)]]</ref>
+
Class/mechanism: Inhibits fibrinolysis by inhibiting plasminogen activators and via antiplasmin activity.<ref name="insert">[http://products.hospira.com/assets/pdfs/EN-1485.pdf Aminocaproic acid (Amicar) package insert]</ref><ref>[[:File:Aminocaproicacid.pdf | Aminocaproic acid (Amicar) package insert (locally hosted backup)]]</ref><ref>[[:File:Aminocaproicacidtablets.pdf | Aminocaproic acid tablets (Amicar) package insert (locally hosted backup)]]</ref>
 
<br>Route: IV, PO
 
<br>Route: IV, PO
 
<br>Extravasation: no information
 
<br>Extravasation: no information
  
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://reference.medscape.com/drug/amicar-aminocaproic-acid-342139 Medscape],[http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
+
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://reference.medscape.com/drug/amicar-aminocaproic-acid-342139 Medscape],[http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
  
 
==Patient drug information==
 
==Patient drug information==
 
*[http://www.uptodate.com/contents/aminocaproic-acid-patient-drug-information Aminocaproic acid (Amicar) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/aminocaproic-acid-patient-drug-information Aminocaproic acid (Amicar) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/aminocaproic-acid-patient-drug-information Aminocaproic acid (Amicar) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/aminocaproic-acid-patient-drug-information Aminocaproic acid (Amicar) patient drug information (UpToDate)]</ref>
 +
 +
==Also known as==
 +
*'''Generic names:''' 6-aminohexanoic acid, epsilon aminocaproic acid, ε-aminocaproic acid, ε-Ahx
 +
*'''Brand name:''' Amicar
  
 
==References==
 
==References==
 
<references/>
 
<references/>
  
[[Category:Drug index]]
+
[[Category:Drugs]]
 +
[[Category:Oral medications]]
 +
[[Category:Intravenous medications]]
 +
 
 
[[Category:Hematology medications]]
 
[[Category:Hematology medications]]
 
[[Category:Hemostasis medications]]
 
[[Category:Hemostasis medications]]
 
[[Category:Fibrinolysis inhibitors]]
 
[[Category:Fibrinolysis inhibitors]]
 +
 +
[[Category:FDA approved in 1964]]

Latest revision as of 03:27, 20 September 2021

General information

Class/mechanism: Inhibits fibrinolysis by inhibiting plasminogen activators and via antiplasmin activity.[1][2][3]
Route: IV, PO
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, Medscape,UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

Also known as

  • Generic names: 6-aminohexanoic acid, epsilon aminocaproic acid, ε-aminocaproic acid, ε-Ahx
  • Brand name: Amicar

References